Varex Imaging (VREX) Cash & Equivalents (2016 - 2026)

Varex Imaging (VREX) has 11 years of Cash & Equivalents data on file, last reported at $85.3 million in Q2 2026.

• On a quarterly basis, Cash & Equivalents fell 58.41% year-over-year to $85.3 million in Q2 2026; TTM through Apr 2026 was $85.3 million, a 58.41% decrease from a year earlier, with the FY2025 full-year figure at $145.0 million, down 14.05% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $85.3 million, down from $119.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for VREX reached as high as $205.1 million in Q2 2025 and fell as low as $81.5 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $131.6 million across 5 years, with a median of $136.4 million in 2025.
• Across the five-year window, Cash & Equivalents soared 73.37% in 2023 and tumbled 58.41% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $81.5 million in 2022, then surged by 73.37% to $141.3 million in 2023, then gained by 19.39% to $168.7 million in 2024, then retreated by 14.05% to $145.0 million in 2025, then sank by 41.17% to $85.3 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $85.3 million in Q2 2026, $119.5 million in Q1 2026, and $145.0 million in Q4 2025.